evaluation, planning, intervention & consulting psychology, pLLC

234 east 32nd street, 4b
new york, new york 10016

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 18, 2013

NYS DOS ID#
4419802

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY

Name History
2013 - EVALUATION, PLANNING, INTERVENTION & CONSULTING PSYCHOLOGY, PLLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Tenement Museum in New York Names Its New President
    By JOSHUA BARONE - Wednesday Jun 14, 2017

    Kevin Jennings, a former nonprofit leader and Obama official, plans to expand the museum’s reach through virtual and augmented reality.

    Source: NYT > Home Page
  • 'NY Times' Finally Joins Snapchat Discover
    Monday Apr 24, 2017

    Does The New York Times joining Snapchat Discover lend an air of respectability to a new platform, and breathe new life into an aging publisher? That's obviously what the partners are planning -- butonly time will tell.

    Source: Media Post: MoBlog
  • Charter promised more broadband but didn’t deliver, now must pay fine
    By Jon Brodkin - Thursday Jun 22, 2017

    21,000 NY customers did not get broadband on schedule, despite merger promise.

    Source: Ars Technica
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Amgen’s Heart Data Don’t Impress Drug-Price Evaluation Group
    By Alex Lash - Tuesday Jun 13, 2017

    The drug-price evaluator that the drug companies love to hate has weighed in again, this time casting a skeptical eye on the price of a next-generation heart medicine from Amgen (NASDAQ: AMGN). The group known as ICER, which stands for Institute for Clinical and Economic Review, released a report today that said Amgen’s evolocumab (Repatha) […]

    Source: Xconomy New York
  • Five Sites of New York’s L.G.B.T. History
    Monday Jun 19, 2017

    Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.

    Source: NYT > Home Page
  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy New York
  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy VC, Deals, & Startups Feed